# E tū / CICTAR — Transparency and Corporate Tax Reforms in Aged Residential Care Funding (2025)

Document ID: doc-0078  
Publisher: E tū / CICTAR  
Catalogue publication date: 2025-05-05  
Physical PDF pages: 21  
Original capture/access label: June 2026  
Source and original reviewed: 9 October 2026

Original local PDF: [Retained original](/pdfs/2025%20-%20E%20tu%20CICTAR%20-%20Transparency%20and%20Corporate%20Tax%20in%20ARC%20Funding.pdf)

Primary publisher source: [Document or publication listing](https://cictar.org/all-research/bupa/nz)

## What the document contributes

Edward Miller’s joint E tū/CICTAR report advocates greater transparency over aged residential care public funding and corporate tax arrangements, drawing on company financial statements and a Bupa New Zealand case study. It compares listed-provider disclosures with privately held providers and proposes a public funding database and tax-policy review. The original distinguishes accounting tax expense from cash tax payments and includes Bupa’s response that it complies with tax law and prices related-party transactions at arm’s length. These are attributed research claims and policy proposals, with no allegation of illegality, rather than an official tax finding or enacted reform.

## Substantive findings

- CICTAR’s listing dates publication to 5 May 2025. The original has 21 physical pages and is prepared by Edward Miller with E tū; its contents include the company response and references (physical pp. 2, 17–21).
- The authors argue that privately held providers’ financial filings do not consistently disclose their ARC public funding, while listed-provider notes provide some subsidy data. They propose a public funding database, not an already operating one (printed pp. 5–6, 15).
- For Bupa Care Services New Zealand Limited over the decade to 31 December 2024, the authors calculate $292.7 million of cumulative pre-tax profit and $11.6 million of net income tax expense, about 4%. These are accounting measures (printed p. 11).
- The same report gives cash tax payments of $24.9 million over that decade, about 8% of pre-tax profit. The roughly $12 million tax-expense headline should not be relabelled as the total cash tax paid (printed p. 11).
- The authors estimate that intercompany interest reduced taxable income by $150.6 million, with a possible $27.1 million revenue effect under their method. This is an attributed estimate, not an Inland Revenue assessment (printed pp. 12–14).
- Recommendations cover funding disclosure, reviewing capital-gains treatment, considering an interest-deduction limit alongside thin-capitalisation rules, and exploring public as well as private provision. They are proposals, not adopted law (printed p. 15).
- The report expressly disclaims allegations of illegality and includes Bupa’s 25 April response: compliance with applicable funding/tax law, arm’s-length related-party pricing and substantial investment in facilities. The response is part of the evidence (physical pp. 2, 17).

## Identity, dates and provenance

The primary CICTAR research listing gives 5 May 2025 and links the full joint report. The local original matches the 21-page structure, including a separate cover, contents/disclaimer page, the company’s response and references. The May 2 PDF metadata is a production timestamp, not the release date. The original file and June 2026 capture label are preserved.

The October 2026 review enriches the catalogue and this editorial companion; it does not replace the original publication date or the June 2026 access/capture label. The original PDF and filename remain unchanged.

## Where to check the original

Physical page 2: authorship, no-illegality disclaimer and response excerpts. Printed pages 3–6 (physical 4–7): ARC funding and disclosure. Printed pages 7–14: Bupa financial case study. Printed page 11 (physical 12): expense versus cash-payment distinction. Printed pages 15–16: recommendations and full company response. Printed pages 17–20: references.

## Evidence limits and use

The authors are union/tax-transparency advocates, and the financial interpretation is not an audit, a court finding or an Inland Revenue assessment. Cash tax timing differs from current/deferred accounting expense, including the report’s discussion of building depreciation changes. The intercompany-interest revenue effect is an estimate and not proven recoverable tax. The report expressly denies alleging illegal conduct, and Bupa states that it complies with law and uses arm’s-length pricing. Some sector totals come from earlier years and extrapolations; they do not provide current occupied-bed counts or current subsidy tariffs. A statement that Phase 2 of Sapere’s review had not been published is not relied on: a July 2024 Phase 2 original exists separately in this library (doc-0076).

## Additional primary sources

- [Primary joint report PDF](https://cictar.org/s/Aged-residential-care-funding-report-2025-E-t-and-CICTAR-FINAL.pdf)